Page last updated: 2024-10-18

glycine and Hemophilia B

glycine has been researched along with Hemophilia B in 6 studies

Hemophilia B: A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)

Research Excerpts

ExcerptRelevanceReference
"A patient with severe haemophilia B with a glycine-to-valine missense mutation at residue 190 (c25, chymotrypsin numbering) in factor IX (FIX; FIX-G190V or FIX-FuChou) had <1% of normal FIX clotting activity and 36% of normal FIX antigen levels (cross-reacting material- reduced, CRMr)."1.37Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B. ( Hamaguchi, N; Kao, CY; Kao, JT; Lin, CN; Lin, SW; Shen, MC; Yang, SJ; Yang, YL, 2011)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, Q1
Yang, L1
Manithody, C1
Wang, X1
Rezaie, AR1
Kao, CY1
Lin, CN2
Yang, YL1
Hamaguchi, N3
Yang, SJ1
Shen, MC3
Kao, JT1
Lin, SW3
Smith, KJ2
Larson, PJ1
Stanfield-Oakley, SA1
VanDusen, WJ1
Kasper, CK1
Monroe, DM1
High, KA1
Wu, PC1
Yu, YS1
Breckenridge, RT1
Ratnoff, OD1

Reviews

1 review available for glycine and Hemophilia B

ArticleYear
Therapy of hereditary disorders of blood coagulation.
    Modern treatment, 1968, Volume: 5, Issue:1

    Topics: Abdomen, Acute; Afibrinogenemia; Blood Coagulation Disorders; Blood Transfusion; Cerebral Hemorrhage

1968

Other Studies

5 other studies available for glycine and Hemophilia B

ArticleYear
Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
    Biochemistry, 2015, Jun-23, Volume: 54, Issue:24

    Topics: Amino Acid Substitution; Cysteine Endopeptidases; Enzyme Activation; Enzyme Precursors; Factor IX; F

2015
Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B.
    Thrombosis and haemostasis, 2011, Volume: 105, Issue:4

    Topics: Animals; Benzamidines; Factor IX; Gene Transfer Techniques; Glycine; HEK293 Cells; Hemophilia B; Hum

2011
Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.
    Blood, 1994, Sep-15, Volume: 84, Issue:6

    Topics: Benzamidines; Binding Sites; Calcium; Codon; Computer Simulation; Electrophoresis, Polyacrylamide Ge

1994
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
    The Journal of biological chemistry, 1996, Feb-16, Volume: 271, Issue:7

    Topics: Adenine; Amino Acid Sequence; Arginine; Base Sequence; Binding Sites; DNA; DNA Mutational Analysis;

1996
Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:4

    Topics: Animals; Blood Coagulation; Cattle; Factor IX; Factor VII; Glycine; Hemophilia B; Humans; Point Muta

2000